The 21st Century Cures Act [HR 6] passed in the House on July 10, 2015 will hopefully move to the Senate for confirmation in the Fall 2015. This important legislation incorporates the President’s Precision Medicine Initiative to focus more aggressively on funding genetically-based research. The bill’s passage would extend funding of the National Institutes of Health [NIH] of $8.75 billion and the Federal Drug Administration of $550 million over the next five years, and establish an Innovation Fund for strategic planning, early stage investigations and research that advances the science of molecular medicine which mirrors ACGT’s model for cancer treatment.
We are asking for your help! Please help push the Bill through. Tell your Senator you believe in the Precision Medicine Initiative.
“HR 6 creates vital funding streams for FDA and NIH that would not likely be available through regular budget processes over the next few years – $8.75 billion for the NIH and $550 million for the FDA. This money will save lives.”
